NCT07209332Phase 2Enrolling by invitation

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

Study sponsor: Wave Life Sciences USA, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-03Estimated
Enrollment · participants175Estimated
Source updated2026-03-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Enrolling by invitation.

Check registry source